RevMAb Biosciences Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 3

Employees
  • Latest Deal Type
  • Debt - PPP

RevMAb Biosciences General Information

Description

Developer of recombinant monoclonal antibodies created to eliminate the generation of hybridoma. The company's antibodies are developed from a broad range of antigen-specific B cells that are inaccessible to traditional hybridoma technology, enabling the medical community to improve treatment outcomes.

Contact Information

Website
www.revmab.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Biotechnology
Primary Office
  • 870 Dubuque Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RevMAb Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - PPP 05-May-2020 00.000 Completed Generating Revenue
2. Later Stage VC 04-Feb-2018 00.000 00.000 Completed Generating Revenue
1. Seed Round 07-Apr-2016 $4.3M $4.3M Completed Generating Revenue
To view RevMAb Biosciences’s complete valuation and funding history, request access »

RevMAb Biosciences Patents

RevMAb Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220089758-A1 Novel anti-cd40 antibodies Pending 22-Jan-2019 00000000000

RevMAb Biosciences Board Members (3)

Name Representing Role Since
Dean Tsao RevMAb Biosciences Board Member 000 0000
George Lee RevMAb Biosciences Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

RevMAb Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial